FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

787994008: Antibacterial therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778326014 Antibacterial therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3778327017 Antibacterial therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antibacterial therapeutic role Is a Therapeutic role false Inferred relationship Existential restriction modifier
Antibacterial therapeutic role Is a Antiinfective therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cefuroxime (as cefuroxime sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 30 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely linezolid 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 1.6 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefoperazone and sulbactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefoperazone and sulbactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefoperazone (as cefoperazone sodium) 500 milligram and sulbactam (as sulbactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin sodium) 250 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ceftriaxone and tazobactam (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ceftriaxone and tazobactam (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ceftriaxone and tazobactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ceftriaxone and tazobactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftriaxone (as ceftriaxone sodium) 1 gram and tazobactam (as tazobactam sodium) 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefuroxime and clavulanic acid (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefuroxime and clavulanic acid (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefuroxime and clavulanic acid in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftazidime 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftazidime 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime (as cefotaxime sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely minocycline (as minocycline hydrochloride) 75 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely daptomycin 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clarithromycin (as clarithromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing bacitracin and neomycin and sulfacetamide (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only bacitracin and neomycin and sulfacetamide (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely meropenem 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely meropenem 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phenoxymethylpenicillin calcium 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and tobramycin (as tobramycin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin hydrochloride) 300 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing procaine benzylpenicillin Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing procaine benzylpenicillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Procaine benzylpenicillin Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only procaine benzylpenicillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing benzathine benzylpenicillin Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing benzathine benzylpenicillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Benzathine benzylpenicillin Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzathine benzylpenicillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ofloxacin (as ofloxacin hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin phosphate) 20 milligram/1 gram conventional release vaginal cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely daptomycin 350 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aztreonam 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amikacin (as amikacin sulfate) 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor anhydrous (as cefaclor) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely diloxanide furoate 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tobramycin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefixime and ofloxacin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefixime and ofloxacin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefixime and ofloxacin in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefixime and ofloxacin in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol 10 milligram and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing benzathine benzylpenicillin and procaine benzylpenicillin Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing benzathine benzylpenicillin and procaine benzylpenicillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzathine benzylpenicillin and procaine benzylpenicillin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzathine benzylpenicillin and procaine benzylpenicillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 21 of 27 Next End

This concept is not in any reference sets

Back to Start